These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 19401958)
21. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Harman SM; Naftolin F; Brinton EA; Judelson DR Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750 [TBL] [Abstract][Full Text] [Related]
22. Effects of endogenous and exogenous estrogen exposures in midlife and late-life women on episodic memory and executive functions. Henderson VW; Popat RA Neuroscience; 2011 Sep; 191():129-38. PubMed ID: 21664950 [TBL] [Abstract][Full Text] [Related]
23. Estrogen replacement therapy and cognitive function in postmenopausal women without dementia. Rice MM; Graves AB; McCurry SM; Larson EB Am J Med; 1997 Sep; 103(3A):26S-35S. PubMed ID: 9344404 [TBL] [Abstract][Full Text] [Related]
25. Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials. Maalouf NM; Sato AH; Welch BJ; Howard BV; Cochrane BB; Sakhaee K; Robbins JA Arch Intern Med; 2010 Oct; 170(18):1678-85. PubMed ID: 20937929 [TBL] [Abstract][Full Text] [Related]
26. Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias. Wharton W; Dowling M; Khosropour CM; Carlsson C; Asthana S; Gleason CE Maturitas; 2009 Nov; 64(3):182-7. PubMed ID: 19879073 [TBL] [Abstract][Full Text] [Related]
27. A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use. Maki PM Ann N Y Acad Sci; 2005 Jun; 1052():182-97. PubMed ID: 16024761 [TBL] [Abstract][Full Text] [Related]
28. Hormone replacement therapy for cognitive function in postmenopausal women. Hogervorst E; Yaffe K; Richards M; Huppert F Cochrane Database Syst Rev; 2002; (3):CD003122. PubMed ID: 12137675 [TBL] [Abstract][Full Text] [Related]
29. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J; JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207 [TBL] [Abstract][Full Text] [Related]
30. Hormone replacement therapy to maintain cognitive function in women with dementia. Hogervorst E; Yaffe K; Richards M; Huppert F Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718 [TBL] [Abstract][Full Text] [Related]
31. Prevention of dementia with sex hormones: a focus on testosterone and cognition in women. Hogervorst E Minerva Med; 2012 Oct; 103(5):353-9. PubMed ID: 23042370 [TBL] [Abstract][Full Text] [Related]
32. [Progesterone+estrogen increased the risk of dementia in postmenopausal women. Surprising results of the WHIM study]. Fried G Lakartidningen; 2003 Sep; 100(36):2742-3. PubMed ID: 14558187 [No Abstract] [Full Text] [Related]
33. Long term hormone therapy for perimenopausal and postmenopausal women. Marjoribanks J; Farquhar C; Roberts H; Lethaby A Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488 [TBL] [Abstract][Full Text] [Related]
34. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies. Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179 [TBL] [Abstract][Full Text] [Related]
35. Risks and benefits of hormone therapy after menopause for cognitive decline and dementia: A conceptual review. Rocca WA; Kantarci K; Faubion SS Maturitas; 2024 Jun; 184():108003. PubMed ID: 38649310 [TBL] [Abstract][Full Text] [Related]
37. Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials. Zec RF; Trivedi MA Climacteric; 2002 Jun; 5(2):122-34. PubMed ID: 12051107 [TBL] [Abstract][Full Text] [Related]
38. Timing of hormone therapy and dementia: the critical window theory revisited. Whitmer RA; Quesenberry CP; Zhou J; Yaffe K Ann Neurol; 2011 Jan; 69(1):163-9. PubMed ID: 21280086 [TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacology and differential cognitive efficacy of estrogen preparations. Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754 [TBL] [Abstract][Full Text] [Related]
40. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N Menopause; 2006; 13(1):139-47. PubMed ID: 16607110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]